磷酸西他列汀 Sitagliptin phosphate ; Sitagliptin phosphate monohydrate ; Sitagliptin ; sitagliptinphosp
西他列汀 Januvia ; Sitagliptin Phosphate ; Jnuvi
磷酸西他列汀一水合物 Sitagliptin monohydrate ; Sitagliptin phosphate monohydrate
磷酸西他列汀杂质A Sitagliptin phosphate impurity
磷酸西他列汀杂质C Sitagliptin phosphate impurity
磷酸西他列汀杂质D Sitagliptin phosphate impurity
磷酸西他列汀杂质J Sitagliptin phosphate impurity
磷酸西他列汀杂质M Sitagliptin phosphate impurity
磷酸西他列汀杂质F Sitagliptin phosphate impurity
磷酸西他列汀杂质K Sitagliptin phosphate impurity
与老年2型糖尿病患者的疗效评估西他列汀两年：事后分析的asset-k研究。
Two-year assessment of the efficacy and safety of sitagliptin in elderly patients with type 2 diabetes: Post hoc analysis of the ASSET-K study.
目的观察吡格列酮和阿托伐他汀联合应用对冠心病合并2型糖尿病PCI术后患者抗炎症作用的影响。
Objective To observe the antiinflammatory effect of pioglitazone combined with atorvastatin in the patients with coronary heart disease complicated with type-2 diabetes after PCI.
应用推荐